THE APEX TIMES
Paramount Primal acquires high-concept thriller spec “Sweet Spot” from Nic Curcio and Kirby Gladstein
The writing duo behind the upcoming indie horror film “Play House” has sold a new high-concept thriller spec to Paramount Primal, with plot details remaining undisclosed.
Paramount Primal has preemptively acquired the high-concept thriller spec “Sweet Spot” from Los Angeles-based writing duo Nic Curcio and Kirby Gladstein, Deadline reported on July 31. The deal marks the latest pickup by the Paramount Pictures unit as it looks to develop new genre material, though no attachment list or plot synopsis has been released publicly.
Deadline reported that Curcio and Gladstein are also behind the upcoming indie horror film “Play House,” which is described as upcoming, but details about that project were not expanded upon in the reporting about “Sweet Spot.” As for “Sweet Spot” itself, the writing duo’s concept is being treated as an early-stage thriller specification, with the story’s premise under wraps at this time.
According to the Deadline report, there were no other named attachments associated with “Sweet Spot” as of the time of publication. That means no director, lead cast, or producing partners were publicly identified in connection with the acquisition in the article.
The transaction was described by Deadline as a preemptive acquisition, indicating Paramount Primal moved early rather than waiting for competing offers to develop. Preemptive purchases are common in the industry for projects expected to attract attention, particularly in the thriller space where tone and originality can be key selling points for studios and streamers.
Paramount Primal’s decision to acquire the spec also underscores the continued flow of thriller and horror development content into major entertainment pipelines. The report did not cite any production timeline or release date, and there are no confirmed milestones beyond the acquisition itself.
Curcio and Gladstein’s involvement brings together their history of writing for genre projects, with Deadline tying them directly to the “Play House” indie horror and now to the “Sweet Spot” thriller spec. For audiences and industry observers, the lack of disclosed plot information suggests the studio is reserving specifics while moving the project through internal development stages.
If “Sweet Spot” advances, additional announcements are expected at later points, typically when attachments are added, budgets or production plans are discussed internally, or when the project enters a formal packaging stage. Until then, Paramount Primal’s acquisition remains the principal publicly confirmed development milestone.
Why It Matters
- The acquisition indicates Paramount Primal’s continued investment in genre thriller development without waiting for competitors, which can affect how quickly subsequent creative teams are assembled.
- Because plot and attachments are not yet public, the next development phase will likely focus on packaging, selecting leadership, and clarifying creative direction.
- The deal reflects ongoing industry demand for high-concept thriller material that can be positioned for studio production or potential distribution partnerships.
- For creators, selling a spec at the development stage can accelerate access to studio resources, but does not by itself confirm production or release timing.
Key Facts
- Paramount Primal acquired the thriller spec “Sweet Spot” from writers Nic Curcio and Kirby Gladstein.
- Deadline reported the acquisition occurred preemptively, moving early in the project’s marketplace window.
- Plot details for “Sweet Spot” have not been disclosed publicly.
- As of Deadline’s report, there were no other attachments named to the “Sweet Spot” project.
- Deadline said Curcio and Gladstein are based out of Los Angeles.
- Deadline tied Curcio and Gladstein to the upcoming indie horror film “Play House” as additional context.